reserpine has been researched along with (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Beleslin, DB; Nedelkovski, V | 1 |
Beleslin, DB; Jovanović-Mićić, D; Nedelkovski, V; Samardzić, R; Strbac, M | 1 |
Daniel, EE; Fox, JE; Jury, J; Robotham, H | 1 |
5 other study(ies) available for reserpine and (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Emesis induced by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343): evidence for a predominant central muscarinic M1 mediation.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; 5,6-Dihydroxytryptamine; alpha-Methyltyrosine; Animals; Antazoline; Bretylium Compounds; Cats; Chlorpromazine; Choline; Emetics; Female; Hemicholinium 3; Hexamethonium Compounds; Injections, Intraventricular; Male; Mecamylamine; Methyltyrosines; Methysergide; Neuromuscular Blocking Agents; Propranolol; Quaternary Ammonium Compounds; Receptors, Muscarinic; Reserpine; Yohimbine | 1988 |
Area postrema: cholinergic and noradrenergic regulation of emesis. A new concept.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Brain Stem; Cats; Cerebral Ventricles; Choline; Emetics; Female; Hemicholinium 3; Hydroxydopamines; Male; Norepinephrine; Oxidopamine; Reserpine; Vomiting | 1989 |
Muscarinic inhibition of canine small intestinal motility in vivo.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acetylcholine; Animals; Atropine; Benzodiazepinones; Dogs; Dose-Response Relationship, Drug; Female; Gastrointestinal Motility; Intestine, Small; Male; Pirenzepine; Receptors, Muscarinic; Reserpine; Tetrodotoxin | 1985 |